Skincare Ingredient Myths: Active Worship and the Natural-vs-Synthetic Myth
Four Frequent Myths
- “Higher concentration is better”: efficacy and irritation rise together; an individual optimum exists — 5% niacinamide beats 20% for most (far higher irritation). The end of the “strong actives” road is a broken barrier (see skincare timing).
- “Natural = safe; chemical = harmful”: toxicology’s basic principle — the dose makes the poison. Natural toxins (essential-oil sensitizers, photosensitizing plants) coexist with safe synthetics (hyaluronic acid). “Chemical” is the name of all matter, not an insult.
- “Stack more layers”: ingredient conflicts and barrier overload — retinoid + acid + high-strength vitamin C in one night is a ruined-face formula. Skincare efficacy lives in “simple routines kept”, not “perfect routines abandoned”.
- “Medical-grade/derm-cosmetics work deeper”: “medical-grade” is mostly positioning; skincare is regulated as cosmetics (definitions of “dermocosmetics” vary) with a real efficacy ceiling — deep structural change needs medicine; skincare wins the surface war.
The Right Frame: Three Jobs of Skincare
- Protection (heaviest weight): sunscreen — the precondition of all efficacy.
- Maintenance: gentle cleansing + moisture + barrier repair — 90% of skincare’s value.
- Actives: problem-targeted ingredients — meaningful only on top of the first two.
What the active layer can’t fix (scars, deep pigment, laxity) goes to devices and medicine — skincare and aesthetics are a relay, not rivals.
Working with Device Programs
- Stop actives pre-treatment; repair first post-treatment (the post-procedure whitelist).
- Post-device skin absorbs more — including irritants: “fast actives after laser” is a PIH-and-sensitivity recipe.
FAQ
“All-natural formulas never irritate”?
Contact-allergen rankings are perennially topped by natural ingredients (fragrance-plant extracts, essential oils) — naturalness says nothing about sensitization; individual patch testing decides.
Are luxury creams worth it?
Buy by the formula, not the story; budget priority: sunscreen > moisturizer > actives. Price-efficacy correlation is weakly supported.
